<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04345380</url>
  </required_header>
  <id_info>
    <org_study_id>1746/2014</org_study_id>
    <nct_id>NCT04345380</nct_id>
  </id_info>
  <brief_title>Rotational Stability of the Acrysof, Tecnis and Envista Intraocular Lenses</brief_title>
  <official_title>Rotational Stability of the Acrysof, Tecnis and Envista Intraocular Lenses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <brief_summary>
    <textblock>
      Brief Summary:&#xD;
&#xD;
      Age-related cataract is the main cause of impaired vision in the elderly population&#xD;
      worldwide. In the UK, more than half of people who are over 65 years old have some cataract&#xD;
      development in one or both eyes. The only treatment that can restore functional visual&#xD;
      ability is cataract surgery where the opacified crystalline lens is removed by&#xD;
      phacoemulsification and an artificial intraocular lens is implanted. It is estimated that&#xD;
      around 10 million cataract operations are performed around the world each year. Cataract&#xD;
      operations are generally very successful, with a low risk of serious complications.&#xD;
&#xD;
      During the past two decades, cataract surgery underwent tremendous change and modernisation&#xD;
      resulting in today's small incision phacoemulsification surgery and a safe technique with a&#xD;
      short rehabilitation time for the patient. Traditional spherical monofocal intraocular lenses&#xD;
      (IOLs) restore best-corrected vision and may lessen the need for spectacles. These IOLs&#xD;
      correct only the spherical portion of the total refractive error and do not correct corneal&#xD;
      astigmatism. Astigmatism is a visually disabling refractive error affecting the general&#xD;
      population, especially those with cataract. At least 15% to 20% of cataract patients have 1.5&#xD;
      diopters (D) or more of corneal or refractive astigmatism. With increased patient&#xD;
      expectations, the trend is not only to remove the cataract but also to address the problem of&#xD;
      pre-existing astigmatism at the time of surgery.&#xD;
&#xD;
      Surgical-induced astigmatism can be reduced by smaller incisions, i.e. microincision cataract&#xD;
      surgery (MICS), which by definition is surgery performed through incisions smaller than 2.0&#xD;
      mm, reducing the need for suturing. This results in better corneal optical quality, thus&#xD;
      improving visual outcomes. There are also other surgical options to correct preexisting&#xD;
      astigmatism during cataract surgery like: selectively positioning of the phacoemulsification&#xD;
      incision; astigmatic keratotomy with corneal or limbal relaxing incisions; excimer laser&#xD;
      refractive procedures such as photorefractive keratectomy, laser in situ keratomileusis, and&#xD;
      laser-assisted subepithelial keratectomy; or implanting pseudophakic toric posterior chamber&#xD;
      intraocular lenses (IOLs).&#xD;
&#xD;
      Toric IOLs have been shown to result in good visual and refractive outcomes. Combined with&#xD;
      MICS, these IOLs can allow effective correction of cylindrical errors intraoperatively,&#xD;
      improving visual quality and thus leading to spectacle independence. Plate haptic and loop&#xD;
      haptic toric IOLs have been considered for about a decade but have been associated with&#xD;
      postoperative rotational instability. Rotation of a toric lens from its intended orientation&#xD;
      degrades its corrective power, with approximately 3.3% loss of cylindrical power for every&#xD;
      degree off axis. A misorientation of approximately 30° negates the effectiveness of&#xD;
      astigmatic correction, and a misorientation of more than 30° may induce additional&#xD;
      astigmatism. Although some patients are asymptomatic despite induced astigmatism, others&#xD;
      experience symptoms such as blurred or distorted vision, headache, fatigue, eyestrain,&#xD;
      squinting, or eye discomfort. Thus, IOL orientation stability is an essential goal in toric&#xD;
      IOL design.&#xD;
&#xD;
      RATIONALE&#xD;
&#xD;
      The purpose of this study is to assess and compare the axial IOL rotation and optical quality&#xD;
      (refraction, visual acuity, decentration and tilt) and capsular bag reaction after&#xD;
      micro-incision surgery with an IOL implantation in cataract patients - Acrysof SN60WF, Tecnis&#xD;
      ZCB00 &amp; Envista MX60 IOL&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 9, 2015</start_date>
  <completion_date type="Actual">August 18, 2017</completion_date>
  <primary_completion_date type="Actual">August 18, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rotational stability from End of Surgery to 6 months</measure>
    <time_frame>4-7 months</time_frame>
    <description>Change in axis position of an intraocular lens Alcon SN60WF, AMO Tecnis ZCB00 or Bausch&amp;Lomb Envista MX60 from end of surgery (baseline axis) to 1 hour, 1 week, 1 month and 4-7 months (end of study visit). The change in axis position will be evaluated with respect to the baseline measurement at the end of surgery. Differences in axis position will be described as rotation in degrees (0 to 360°)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Decentration</measure>
    <time_frame>4 to 7 months</time_frame>
    <description>Decentration of the intraocular lens Alcon SN60WF, AMO Tecnis ZCB00 or Bausch&amp;Lomb Envista MX60 will be measured with a Purkinje Meter. Decentration will be described as &quot;Decentration in milimeter&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tilt</measure>
    <time_frame>4 to 7 months</time_frame>
    <description>Tilt of the intraocular lens Alcon SN60WF, AMO Tecnis ZCB00 or Bausch&amp;Lomb Envista MX60 will be measured with a Purkionje Meter. Tilt will be described as &quot;Tilt in degrees at a certain axis&quot;</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">199</enrollment>
  <condition>Cataract</condition>
  <condition>Astigmatism</condition>
  <arm_group>
    <arm_group_label>Acrysof Rotation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Implantation of the Acrysof SN60WF Intraocular lens to the 0 ±10, 45± 10, 90±10 or 135± axis.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tecnis Rotation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Implantation of the Tecnis ZCB00 Intraocular lens to the 0 ±10, 45± 10, 90±10 or 135± axis.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Envista Rotation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Implantation of the Envista MX60 Intraocular lens to the 0 ±10, 45± 10, 90±10 or 135± axis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Implantation of an Alcon Acrysof SN60WF intraocular lens</intervention_name>
    <description>Patients suffering from senile cataract getting replaced their human crystalline cataractous lens</description>
    <arm_group_label>Acrysof Rotation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Implantation of an AMO Tecnis ZCB00 intraocular lens</intervention_name>
    <description>Patients suffering from senile cataract getting replaced their human crystalline cataractous lens</description>
    <arm_group_label>Tecnis Rotation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Implantation of an Envista MX60 intraocular lens</intervention_name>
    <description>Patients suffering from senile cataract getting replaced their human crystalline cataractous lens</description>
    <arm_group_label>Envista Rotation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Uni- or bilateral age-related cataract necessitating phacoemulsification extraction&#xD;
             and posterior IOL implantation&#xD;
&#xD;
          -  Need for spherical IOL correction between 10.00 and 30.00 D&#xD;
&#xD;
          -  Pupil dilation of ≥ 6.5 mm&#xD;
&#xD;
          -  Age 40 and older&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Corneal abnormality&#xD;
&#xD;
          -  Pseudoexfoliation&#xD;
&#xD;
          -  Preceding ocular surgery or trauma&#xD;
&#xD;
          -  Uncontrolled glaucoma&#xD;
&#xD;
          -  Proliferative diabetic retinopathy&#xD;
&#xD;
          -  Iris neovascularization&#xD;
&#xD;
          -  History of uveitis/iritis&#xD;
&#xD;
          -  Microphthalmus&#xD;
&#xD;
          -  Recurrent intraocular inflammation of unknown etiology&#xD;
&#xD;
          -  Blind fellow eye&#xD;
&#xD;
          -  Uncontrolled systemic or ocular disease&#xD;
&#xD;
          -  Pregnancy and lactation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Medical University of Vienna Allgemeines Krankenhaus</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 8, 2020</study_first_submitted>
  <study_first_submitted_qc>April 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 14, 2020</study_first_posted>
  <last_update_submitted>April 10, 2020</last_update_submitted>
  <last_update_submitted_qc>April 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Rupert Menapace</investigator_full_name>
    <investigator_title>Univ. Prof. Dr. med.univ. Rupert Menapace</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Astigmatism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

